Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O2XW
|
|||
| Former ID |
DIB009826
|
|||
| Drug Name |
VT-111a
|
|||
| Indication | Acute coronary syndrome [ICD-11: BA41; ICD-9: 411.1] | Phase 2 | [1] | |
| Company |
Viron therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Serine protease unspecific (SP) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Avarx. | |||
| REF 2 | Viral Serpin Therapeutics: From Concept to Clinic. Methods Enzymol. 2011; 499: 301-329. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.